Golam Iftakhar I. Khandakar

Teruaki Takasaki ,Yasuyuki Hamabe , Kenta Touchi , Golam Iftakhar Khandakar , Takeshi Ueda , Hitoshi Okada, Kazuko Sakai, Kazuto Nishio, Genzoh Tanabe and Reiko Sugiura 2024. ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells Oxidative Medicine and Cellular Longevity, 2024 ,

Golam Iftakhar Khandakar , Yoichi Miyamoto, Ryosuke Satoh, Kenta Kishimoto, Mingzuo Xie, Mengyu Shih, Teruaki Takasaki , Genzoh Tanabe , Masahiro Oka, Reiko Sugiura 2023. ACAGT-007a, an anti-cancer compound that modulates ERKMAPK signaling, induces nuclear enrichment ofphosphorylated ERK in T3M4 pancreatic cancer cells Genes to Cells, 28 6, 457-465

Teruaki Takasaki, Reo Obana, Daiki Fujiwara, Naofumi Tomimoto, Golam Iftakhar Khandakar, Ryosuke Satoh, and Reiko Sugiura 2023. ACA-28, an anticancer compound, induces Pap1 nuclear accumulation via ROS-dependent and -independent mechanisms in fission yeast microPublication Biology, ,

Golam Iftakhar Khandakar , Ryosuke Satoh , Teruaki Takasaki , Kana Fujitani , Genzoh Tanabe , Kazuko Sakai , Kazuto Nishio , Reiko Sugiura 2022. ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells Cells, 11 4, 702